Jeff Yass’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIB
HAIM
WN
MAWA
IWA
BCM
Jeff Yass's TRIB Position: Q2 2026 in Review
Jeff Yass opened a new position in Trinity Biotech (TRIB) in Q2 2026: 895 shares worth $10.4K. The stake represents ﹤0.01% of the portfolio and ranks #13124 among its holdings. This is a return to the name: Jeff Yass previously reported a position in TRIB as recently as Q4 2025.
Jeff Yass first reported a position in TRIB in Q3 2013 and has held it in 25 quarters since. The position peaked at $1.02M in Q2 2014. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.
- Jeff Yass held 895 shares of Trinity Biotech worth $10.4K as of Q2 2026.
- Trinity Biotech was a new Jeff Yass position in Q2 2026.
- Trinity Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13124 holding.
- Jeff Yass first reported a position in Trinity Biotech in Q3 2013 and has held it in 25 quarters since.
- Jeff Yass's Trinity Biotech position peaked at $1.02M in Q2 2014.
- 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.